Delay of Otsuka's $886 Million Bid For Astex Could Draw More Suitors
This article was originally published in PharmAsia News
Executive Summary
Otsuka Pharmaceutical's $886 million offer to acquire Astex Pharmaceuticals is set to expire Oct. 10, an event that could trigger even bigger offers from other suitors at year's end.